Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
University of Cincinnati
The two aims of the study test the hypotheses that correcting omega-3 fatty acid deficiency in the early stages of schizophrenia improves positive symptom treatment response, negative symptom treatment response, and cognition symptom response.
Age
8–25
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Between the ages of 8-25 years.
Diagnosis of MDD and not exhibited symptom remission CDRS-R (\> 28 but \< 40) despite being administered a standard therapeutic dose of an SSRI continuously for a minimum of 6 weeks.
Ability and willingness to provide assent and informed, written consent from at least one biological parent.
Present with biological parent or legal guardian.
Willingness to maintain current dietary habits.
Permission from treating physician
Able to perform fMRI/MRS.
You may not be if
Inability or unwillingness to provide consent.
Antecedent or concurrent serious medical illness.
Clinically unstable medical disease, including cardiovascular, hepatic insufficiency, severe renal impairment, gastrointestinal, pulmonary, metabolic, endocrine, obesity or other systemic disease.
History of seizures, excluding febrile seizures in childhood.
Patients requiring treatment with any drug which might obscure the action of the study treatment.
Female patients who are either pregnant or lactating.
Clinically significant laboratory abnormalities in the last year on CBC or TSH tests.
Judged clinically to be at suicidal risk (defined as having active suicidal ideation, intent or plan, or a serious suicide attempt within the past 6 months, or a baseline CDRS-R suicide score of \>3).
Hospitalized within the last 3 months
Greater than 1 year outside appropriate age/grade level
Pacemaker
Cerebral aneurysm clip
Cochlear implant
Metal fragments lodged within the eye or braces
Claustrophobia
Necessity of sedation (no sedation will be given).
History of loss of consciousness \> 10 minutes in duration
Allergy to seafood.
Clareo Health | Omega-3 Fatty Acid Deficiency Replacement in Early Schizophrenia
